InChI=1S/C15H20O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13-14,16H,2-4,9H2,1H3,(H,17,18)/t10-,13+,14-/m0/s1 |
SHAHPWSYJFYMRX-GDLCADMTSA-N |
C[C@H](C(O)=O)c1ccc(C[C@H]2CCC[C@@H]2O)cc1 |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor
A compound or agent that combines with cyclooxygenases (EC 1.14.99.1) and thereby prevents its substrate-enzyme combination with arachidonic acid and the formation of icosanoids, prostaglandins, and thromboxanes.
xenobiotic metabolite
Any metabolite produced by metabolism of a xenobiotic compound.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
drug metabolite
|
|
non-steroidal anti-inflammatory drug
An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
antipyretic
A drug that prevents or reduces fever by lowering the body temperature from a raised state. An antipyretic will not affect the normal body temperature if one does not have fever. Antipyretics cause the hypothalamus to override an interleukin-induced increase in temperature. The body will then work to lower the temperature and the result is a reduction in fever.
|
|
View more via ChEBI Ontology
Outgoing
|
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has functional parent
loxoprofen
(CHEBI:76172)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has functional parent
propionic acid
(CHEBI:30768)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has role
antipyretic
(CHEBI:35493)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has role
drug metabolite
(CHEBI:49103)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has role
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor
(CHEBI:35544)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has role
human metabolite
(CHEBI:77746)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has role
non-narcotic analgesic
(CHEBI:35481)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has role
non-steroidal anti-inflammatory drug
(CHEBI:35475)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
has role
xenobiotic metabolite
(CHEBI:76206)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
is a
cyclopentanols
(CHEBI:23495)
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
(CHEBI:76204)
is a
monocarboxylic acid
(CHEBI:25384)
|
|
(2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid
|
loxoprofen active metabolite
|
ChEBI
|
loxoprofen-SRS
|
ChEBI
|
5745713
|
Reaxys Registry Number
|
Reaxys
|
14980665
|
PubMed citation
|
Europe PMC
|
15501405
|
PubMed citation
|
Europe PMC
|
16272692
|
PubMed citation
|
Europe PMC
|
16406342
|
PubMed citation
|
Europe PMC
|
9650852
|
PubMed citation
|
Europe PMC
|
9831331
|
PubMed citation
|
Europe PMC
|
|